Phase I clinical trial of HC ‐1119: A deuterated form of enzalutamide-Reference-Cited by-同舟云学术

Phase I clinical trial of HC ‐1119: A deuterated form of enzalutamide

Published:2021-07-07 Issue: Volume: Page:
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Li Xiaoyu¹²,Cheng Ke³,Li Xinghai⁴,Zhou Yuwen⁵,Liu Jiyan⁵^ORCID,Zeng Hao⁶,Chen Yuanwei⁴,Liu Xiao⁷,Zhang Ying⁷,Wang Yongsheng²⁸,Bi Feng³,Zheng Li¹^ORCID

Affiliation:

1. Institute of Clinical Pharmacology, GCP center, West China Hospital Sichuan University Chengdu China

2. State Key Laboratory of Biotherapy Sichuan University Chengdu China

3. Department of Abdominal Oncology, West China Hospital Sichuan University Chengdu China

4. Hinova Pharmaceuticals Inc. Chengdu China

5. Department of Biotherapy, Cancer Center of West China Hospital Sichuan University Chengdu China

6. Department of Urology, Institute of Urology, West China Hospital Sichuan University Chengdu China

7. Haisco Pharmaceuticals Inc. Shanghai China

8. Institute of Clinical Pharmacology, GCP center Department of Thoracic Chengdu China

Funder

Department of Science and Technology of Sichuan Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33706

Reference22 articles.

1. Cancer statistics, 2019

2. PSA Decline Is an Independent Prognostic Marker in Hormonally Treated Prostate Cancer

3. Carcinoma of the Prostate

4. A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma

5. Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deuterium Editing of Small Molecules: A Case Study on Antitumor Activity of 1,4-Benzodiazepine-2,5-dione Derivatives;Journal of Medicinal Chemistry;2024-07-19

2. Precision Deuteration in Search of Anticancer Agents: Approaches to Cancer Drug Discovery;Cancer Biotherapy and Radiopharmaceuticals;2023-08-16

3. Deuterium in drug discovery: progress, opportunities and challenges;Nature Reviews Drug Discovery;2023-06-05

4. Consensus on safety management of novel hormonal therapy for advanced prostate cancer;UroPrecision;2023-06

5. Androgen receptor pathway inhibitors, prostate cancer, and older adults: a global Young International Society of Geriatric Oncology drug review;Therapeutic Advances in Medical Oncology;2023-01